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ABSTRACT 
The aim of radiation therapy treatment planning is to achieve an optimal balance between delivering a high dose to target 
volume and a low dose to healthy tissues. The integral dose, conformity and homogeneity indexes, hence, are the 
important guidance for predicting the radiation effects and choosing the optimal treatment plan. The goal of this study is to 
compare and investigate the aforementioned parameters in 3DCRT vs. IMRT plan. In order to evaluate dosimetric 
parameters, data from five patients with prostate cancer, planned by IMRT and 3DCRT were obtained. Prescribed doses 
for IMRT procedure and 3DCRT were 80Gy and 70 Gy, respectively. Also, the target coverage was achieved with 95% of 
the prescribed dose to 95% of the PTV in 3DCRT and 95% of the prescribed dose to 98% of the PTV in IMRT method. A 
total of thirty IMRT and 3DCRT plans were performed for evaluation of dosimetric parameters (for each patient both 
treatment plans, step and shoot IMRT and 3DCRT with 6, 10 and 18MV energies) were done. The integral dose was 
calculated as the mean- dose times the volume of the structure. The mean integral dose (ID) received by rectum for 
3DCRT was almost 1.01% greater than IMRT while in bladder mean value of ID for IMRT was approximately 1.68% higher 
than 3DCRT. For PTV in IMRT the ID of target volume had the biggest value (1.14%) compared to that of 3DCRT. Dose 
conformity in PTV volume in S.A.S and 3DCRT was almost equal. The same outcome was achieved in homogeneity 
index. The results of this study shows that IMRT method leads to adequate target dose coverage while the prescribed 
dose for this modality is higher than 3DCRT. IMRT has the ability of increasing the maximum dose to tumor region and 
improves conformity and homogeneity indexes in target volume and also reduces dose to OAR. 
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1. Introduction  
Clinicians are still looking for the optimal planning methods of treating prostate cancer with external beam radiation 
therapy. The role of radical dose in radiation therapy has been established in the management of non-metastatic prostate 
cancer [1].  
Previously, radiation treatment was matched to the height and width of the target volume, meaning that the normal 
structures were exposed to the beams.  Advances in imaging technology have made it feasible to locate and treat the 
tumor more precisely. In recent years, 3 Dimensional Conformal Radiation Therapy or so called 3DCRT has commonly 
been used. By using CT or MRI scans tumor can be seen in three dimensions. Therefore, we can design the therapeutic 
fields that follow the shape of the tumor more closely. Thus, the radiation beam would provide better dose distribution in 
target volume while spares healthy tissues as far as possible.    
The need for Intensity Modulated Radiation Therapy (IMRT) arised from the requirement to sculpt precise dose 
distributions which conform in three dimensions to the shape of planning target volumes (PTVs) and spares organs at risk 
(OARs) [2]. Nowadays, IMRT has its own place for treatment of variety of cancers. As like 3DCRT, IMRT models the 
radiation beams to closely fit the region where the tumor is.  
IMRT can also create a concave area within the radiotherapy field to spare normal structures that would be damaged by 
the radiotherapy. This is very useful in regions such as prostate, for example to bring out the rectum or bladder. Hence, 
IMRT leads to better conformity of dose distribution to the target volume than 3DCRT. The basic principle of IMRT 
involves irradiation from a number of different beam directions with nonuniform energy fluences, which have been 
optimized to deliver a high dose to the target volume and acceptably low dose to the surrounding normal structures [3]. 
The treatment planning program divides each beam into a large number of beamlets and determines the optimum setting 
of their energy fluences or beam weights [3].  IMRT increases the volume of normal tissue exposed to some radiation but 
can reduce the total dose received by critical structures [4]. In addition of mentioned advantages of IMRT over 3DCRT, 
IMRT can enhance the fluence at margins of the target and compensate the portal boundaries [5]. Another distinct 
advantage offered by IMRT is that it makes it possible to deliver different doses to different target volumes in a single plan, 
commonly referred to a Simultaneously Integrated Boos IMRT (SIB IMRT) [5].    
Integral Dose (ID) is the volume integral of the dose deposited in a patient and is equal to the mean dose times the volume 
irradiated to any dose [3]. The ID is also the area under the curve of a differential absolute-volume histogram [6]. It is often 
stated that the large number of beamlets and monitor units used in IMRT leads to an increase in ID [7] and that higher-
energy photon beams substantially reduce the normal tissue ID (NTID) [9]. In contrast, an alternative hypothesis suggests 
that the total energy deposited in a patient during irradiation (ID) is relatively independent of treatment planning 
parameters [6]. The aim of this study is to compare the integral dose and also the dose distribution for these two 
techniques based on the dose volume histogram (DVH) analysis of the target and critical organs. This treatment planning 
study also is designed to address the two following important issues: whether step and shoot IMRT technique increases 
conformity index compared to 3DCRT, and whether the use of  IMRT method reduces  homogeneity index or not? 
2. Materials and Methods 
2.1. Requirements  
At the onset of the study five patients with prostate cancer were selected to be planned with external beam radiation 
therapy for the future analysis. Planning computed tomography (CT) images with slice thickness of 3mm was attained for 
all patients while they were fixed in supine form.  Target volumes and Organs at Risk (OAR) were contoured using M.I.R.S 
(version 5 Nuclemed, Boins Ayros, Argentina) which utilizes Scatter Integration algorithm to calculate the dose distribution.  
The clinical linear accelerators (Elekta, Precise model, United kingdom) which produces three ranges of photon energies 
6, 10, and 18MV and integrated with 80 pairs of leaves (MLCs) was utilized for step and shoot IMRT and 3DCRT. The 
collimator angle was defined zero for all therapeutic fields which were used for IMRT and 3DCRT, and also each of IMRT 
beams has 11segments. 
2.2. Integral dose definition  
Integral dose is the total energy absorbed by the body, and is computed based on the average organ density, averaged 
organ dose, and volume as defined in equation (1): 
  V   (Gy.Kg) [11]   (Eq.1) 
Where   ,  and V are averaged organ dose, averaged organ density and volume, respectively [11].In this study the 
integral dose is calculated by equation (2): 
Integral Dose=Average Dose * Volume (Gy.Lit) (Eq.2) 
2.3. Homogeneity and conformity indexes   
Dose homogeneity and dose conformity are independent specifications for evaluating plan quality. Dose homogeneity 
characterizes the uniformity of dose distribution within the target volume and dose conformity specifies the degree to 
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which the high dose region conforms to the target volume, usually the PTV [12].  In this study, the target dose conformity 
and uniformity are measured and estimated according to ICRU83 which are shown in equations 1 and 2. 
The conformity index (CI) is defined as following: 
 CI (ref) = Volume of PTV covered by the reference dose/Volume of PTV and CI = 1.0 is the ideal value. (Eq.3). 
HI = (D2 % – D98 %) / D50 % (Eq.4) 
 Where, D 2%, D 98% and D 50% are the doses received by 2%, 98%, 50% of  the volume and HI = 0 (Zero) is ideal value 
2.4. Treatment Planning  
All patients were planned with both techniques: IMRT and 3DCRT. For step and shoot technique the PTV was created 
using 10 mm three dimensional margining around the CTV (CTV is considered as prostate plus seminal vesicles) except 
towards rectum that was increased 8mm. In 3DCRT the PTV was also created by addition of 10 mm margin around CTV 
similar to IMRT techniques and 6mm in the direction of rectum.  
The prescribed doses for IMRT treatment plans and 3DCRT were considered 80 and70Gy, respectively. Dose per fraction 
was also considered 2Gy. Dose volume Constraints (DVCs) for IMRT are shown in Table1. 
The maximum and minimum doses for PTV were measured by prescribed dose (80Gy) time to 102% and 98%, as upper 
and lower constraints, respectively. For 3DCRT five fields have the same weight (40cGy for each beam) and dose per 
fraction was considered 2Gy. Both treatments were normalized to isocenter which was placed in the center of PTV.  
 For 3DCRT the whole PTV was set to receive at least 95% of the prescribed dose and in IMRT the mentioned conditions 
were used to achieve the minimum criteria of 98% of the target volume receives 95% of the prescribed dose. Therefore, 
the average doses, the volume of all regions (in both methods) in three ranges of energies (6, 10 and 18 MV) were 
achieved to calculate and compare the integral dose in step and shoot IMRT vs. 3DCRT. 
Table 1. DVCs for S.A.S IMRT 
Structures  DVC(Gy) 
PTV 
 Dose max = 8160 
Dose min = 7840 
Rectum 
  D60≤4560 
  D30≤7200 
D5≤8000 
Bladder 
  D50≤5680 
  D20≤6800 
D5≤8000 
Right Femur Head  D50≤5680 
Left Femur Head  D50≤5680 
 
3. Results  
3.1. Integral dose 
The volume, average dose and IDs of PTV, bladder and rectum are summarized in tables2, 3, and 4. 
Table2. The volume of PTVs and OARs 
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Table3. The average and integral dose of PTV for IMRT and 3DCRT 
 
    IMRT 3DCRT 
    PTV PTV 
Energy   D avrag(Gy) ID(Lit.Gy) D avrag(Gy) ID(Lit.Gy) 
6MV 
Patient 1 80.13 34.31 70.76 29.65 
Patient 2 78.85 25.78 71.01 22.49 
Patient 3 79.83 31.49 70.57 27.16 
Patient 4 78.24 18.01 71.41 16.83 
Patient 5 79.08 23.53 71.14 20.55 
10MV 
Patient 1 79.88 34.21 70.93 29.71 
Patient 2 79.98 31.55 71.07 22.51 
Patient 3 79.37 25.95 70.74 27.23 
Patient 4 78.91 18.16 71.33 16.8 
Patient 5 78.79 23.44 71.24 20.37 
18MV 
Patient 1 79.86 34.2 70.32 29.45 
Patient 2 79.54 26.00 70.58 22.35 
Patient 3 79.90 31.52 70.26 27.04 
Patient 4 79.61 18.23 70.61 16.63 
Patient 5 78.85 23.46 71.10 20.54 
 
Rectum and bladder have the same volume in all patients, while the volume of PTV in 3DCRT is totally different with PTV 
in IMRT. Because of the identical volume in body for each case (Table2) and also regarding to the integral dose formula, it 
is obvious that the average dose has the radical role in amount of integral dose. Thus, plainly in the regions with equal 
volume (rectum and bladder) treated by each methods, the main affecting factor on integral dose is the average dose.  
Table3 shows the data used for calculating integral dose of IMRT and 3DCRT. 
Because of the greatest average dose and volume for PTV in IMRT the integral dose has increased, noticeably. According 
to table3 for PTV the integral dose in IMRT is about 1.14% higher than 3DCRT and in both of treatment modalities the 
integral dose decreases with increasing energies, Figure1.  
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Table 4 shows the data achieved for OARs. 
Table4. The average and integral dose in OARs for IMRT and 3DCRT 
IMRT 3 DCRT 
    Bladder Rectum Bladder Rectum 










45.80 7.73 59.67 5.31 45.54 3.454 64.27 5.72 
patient 
2 
61.01 5.06 54.01 4.02 61.51 3.639 57.56 4.29 
patient 
3 
55.66 9.19 46.62 8.79 57.66 3.153 46.46 8.76 
patient 
4 
56.69 6.29 39.97 5.13 58.31 3.015 44.57 5.72 




44.31 7.48 59.64 5.3 45.83 3.65 63.66 5.66 
patient 
2 
60.19 4.99 54.37 4.53 61.54 3.786 56.96 4.24 
patient 
3 
55.87 9.22 46.03 8.68 57.51 3.355 45.85 8.64 
patient 
4 
57.48 6.38 40.07 5.14 58.40 3.219 43.75 5.61 




43.42 7.33 59.02 5.25 45.64 3.706 62.37 5.52 
patient 
2 
60.60 5.03 54.47 4.06 61.42 3.877 56.14 4.18 
patient 
3 
55.08 9.09 44.96 8.47 57.13 3.403 44.80 8.44 
patient 
4 
56.69 6.29 39.02 5.03 57.67 3.24 42.95 5.51 
patient5 58.61 6.15 48.88 8.42 60.55 6.36 52.29 9.02 
 
In rectum, the mean value of ID for IMRT is about 1.01% lesser than 3DCRT, while in bladder the inverse trend is 
observed and the mean value of ID for IMRT is about 1.68% greater than 3DCRT. Irrespective to the increasing of integral 
dose, the average dose in bladder and rectum is reduced by IMRT technique. As the other studies show in IMRT and 
especially for S.A.S technique, because of increasing in the MU and time of treatment, the integral dose goes up. The data 
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Table5. The average data of integral dose and average dose 
    Bladder Rectum 
    IMRT 3DCRT IMRT 3DCRT 






avr(Gy) ID(LIT.Gy) D avr(Gy) ID(LIT.Gy) 
The Average of 6 
MV data 55.57 6.86 56.58 3.94 49.88 6.34 53.06 6.7 
The Average of 10 
MV data  55.28 6.82 56.89 4.08 49.86 6.42 52.52 6.63 
The Average of 18 
MV data  54.88 6.77 56.48 4.11 49.27 6.24 51.71 6.53 
The Average of all 
data  55.24 6.83 56.75 4.05 49.67 6.34 52.43 6.62 
 
 
The dose distribution in axial sections are shown in Figures 2a, 2b and 2c for 18MV photon beams. These axial sections 
clearly show the concave PTV coverage and exclusion of rectum and bladder during optimization by step and shoot IMRT. 
 
Fig 2a. Axial section dose distribution in IMRT 
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The Dose Volume Histograms (DVH) achieved for bladder in both techniques are shown in Figures3a and 3b. 
 
Fig 3a. DVHs of bladder in IMRT 
 
 
Fig 3b. DVHs of bladder in 3DCRT 
 
3.2. Homogeneity index conformity index(H.I and C.I) 
The planning objectives are met in the selected patients with three techniques. 3DCRT plans frequently showed hotspots 
near the rectum and bladder wall but within the acceptable limit. The normalized target coverage of both IMRT methods 
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 Table 6. Comparison of data achieved in two methods of treatment 
Type of 
treatment 












6MV 8085 7161 8485 0.16376 0.429 39.39078 0.9182 
10MV 8044 7029 8441 0.175535 0.429 38.92317 0.9073 
18MV 8046 7000 8455 0.180835 0.429 38.83308 0.9052 
Patient2 
6MV 7970 6661 8367 0.214053 0.327 27.42876 0.8388 
10MV 8014 6735 8382 0.205515 0.327 27.85059 0.8517 
18MV 8044 6750 8411 0.206489 0.327 28.24953 0.8639 
Patient3 
6MV 8000 7000 8411 0.176375 0.395 36.1346 0.9148 
10MV 8029 7014 8323 0.163034 0.395 35.69615 0.9037 
18MV 8029 7000 8367 0.170258 0.395 35.708 0.904 
Patient4 
6MV 7897 6808 8470 0.21046 0.247 20.25894 0.8202 
10MV 7926 6897 8558 0.209563 0.247 21.25682 0.8606 
18MV 8044 6794 8573 0.221159 0.247 21.6372 0.876 
Patient5 
6MV 8029 6632 8500 0.232657 0.31 25.0573 0.8083 
10MV 7985 6633 8470 0.230056 0.31 24.8434 0.8014 
18MV 7985 6558 8485 0.241327 0.31 25.4293 0.8203 
3DCRT 
Patient1 
6MV 7054 6776 7517 0.105047 0.419 41.73659 0.9961 
10MV 7067 6789 7491 0.099335 0.419 41.77011 0.9969 
18MV 7035 6774 7364 0.083866 0.419 41.56061 0.9919 
Patient2 
6MV 7082 6682 7388 0.099689 0.317 31.44323 0.9919 
10MV 7094 6787 7364 0.081336 0.317 31.48761 0.9933 
18MV 7035 6670 7282 0.086994 0.317 31.34179 0.9887 
Patient3 
6MV 7047 6705 7388 0.096921 0.385 38.1304 0.9904 
10MV 7058 6741 7388 0.091669 0.385 38.1304 0.9904 
18MV 7023 6682 7270 0.083725 0.385 38.1535 0.991 
Patient4 
6MV 7133 6591 7615 0.143558 0.236 23.02652 0.9757 
10MV 7133 6604 7544 0.131782 0.236 22.89436 0.9701 
18MV 7058 6582 7441 0.121706 0.236 22.6914 0.9615 
Patient5 
6MV 7070 6776 7346 0.080622 0.298 29.6659 0.9955 
10MV 7070 6800 7317 0.073126 0.298 29.76722 0.9989 
18MV 7023 6741 7230 0.069628 0.298 29.63908 0.9946 
 
ISSN 2347-3487                                                           
1046 | P a g e                                                      O c t o b e r  2 8 ,  2 0 1 4  
There is a steady improvement in C.I for PTV volume from 0.99891 in 3DCRT planned by 10MV photon beams to 0.8014 
in S.A.S IMRT planned by 10MV photon beams (patient5). The H.I is improved from 0.241327 in IMRT for 18MV photon 
beams to the lesser value of 0.069628 in the 3DCRT for 18MV photon beams (patient5). 
4. Discussion 
Commonly, both IMRT and 3DCRT techniques lead to the same outcomes regarding PTV coverage. Both plans were 
assessed by using the following criteria:  
95% of the prescribed dose should be delivered to 95% of PTV for 3DCRT and also 95% of the prescribed dose should be 
delivered to 98% of target volume for IMRT Fig2a, 2b. Integral dose or total cumulative dose to normal untreated tissues is 
higher in IMRT as compared to conventional treatments [13,14]. Compared to conformal prostate radiotherapy IMRT 
provided better normal tissue sparing and consequently further reduction of rectal toxicity and late effects. The inverse-
planned IMRT further reduce hotspots, because of beam modulation during optimization compared to 3DCRT [15].  
The monitor unit for IMRT was 6-8 times more than 3DCRT [5]. This shows that the integral dose would also be higher. 
This result is consistent with Pirzkall et al who concluded that the integral dose for IMRT is higher than conventional 
treatment [14]. According to the achieved data, integral dose in rectum for IMRT is almost equal to 3DCRT (table 4 and 5). 
In PTV and bladder the integral dose increased for IMRT in comparison to 3DCRT. The increasing of ID in PTV due to 
greater volume and average dose is absolutely logical, but in bladder while the average dose in IMRT method had the 
lesser value (table5) in comparison to 3DCRT, the integral dose has jumped up because of the increasing of monitor unit 
and irradiation time.   
In general, high integral dose can be attributed to secondary malignancies for patients with a low risk for systemic relapse 
after treatment.  
In addition, S.A.S IMRT and 3DCRT provided similar results regarding to the percentage of PTV volume which received 
the definitive isodose (95% of the prescribed dose), as identified in table 7. 
Table7. The percentage of PTV volume that covered by certain isodose 
  Step and shoot IMRT 3DCRT 
Energy  6MV 10MV 18MV 6MV 10MV 18MV 
The percentage of PTV volume which 
received the desired dose 
94.25 94.32 94.69 94.73 94.6 93.14 
 
Depth analysis of dosimteric data revealed significant differences in amount of target coverage (Table 6). By use of the 
same therapeutic fields for each technique and according to the ICRU 83 guideline about the accredit amount of C.I and 
H.I, the obtained values are acceptable. Thus, this arrangement of beams improved homogeneity and conformity indexes, 
also reduced the volume of OARs such as the rectum and bladder receiving a high dose.  
IMRT for prostate cancer is explored for its ability to conform the dose distribution to the concavity of target volume. With 
increasing sophistication in radiation treatment plans, homogeneity indexes showed improvement with inverse-planned 
IMRT as reported by Fisher [16]. Compared to 3DCRT, IMRT proved better normal tissue sparing. The potential 
advantages of IMRT technique over conventional 3D and non-3D techniques are (1) the ability to achieve dose uniformity 
throughout the PTV (2) the potential to reduce the dose to OARs. These abilities are expected to translate into improved 
cosmetic results and reduced toxicity.  
Despite  3DCRT, S.A.S radiotherapy provides better target coverage (Table 8), but 3DCRT has averagely acceptable 
mean value in H.I (0.1884) vs. step and shoot technique (0.1515), in three ranges of energies. For the C.I by regarding the 
goal of ICRU 83(C.I= 1 is ideal) the 3DCRT shows better results over S.A.S IMRT except in 18MV (Table 7) but 
irrespective to the discrepancy in prescribed dose (10Gy) IMRT has shown better results, averagely. The IMRT plans 
contributed a higher dose to adjacent normal tissues and causes to increase the prescribed dose to target volume. 
 
Table 8.  The average of H.I and C.I in three methods and energies 
  Step and shoot IMRT 3DCRT 
The average of H.I in 3 range of 
energies  
0.1515 0.1884 
The average of C.I in three ranges of 
energies  
0.944 0.941 
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5. Conclusion   
In general, multiple-field radiation leads to decrease the volume of healthy tissues that received high dose of radiation and 
increase the volume receiving low-dose radiation. Therefore, theoretically, there may be an increased risk of second 
malignancies. However, this can be rather difficult to interpret when we apply it to modern radiation techniques in which 
multiple radiation fields are used [3].  There is little difference between 3DCRT and IMRT, for three ranges of energies 6, 
10 and 18MV, in the ID to the rectum while for bladder the cumulative dose has been higher in IMRT Vs. 3DCRT. The little 
difference in ID in rectum originated from the greater average dose in 3DCRT treatment planning in comparison of step 
and shoot procedure (table4, 5) and in bladder, the reduction of average dose in IMRT compared to that of 3DCRT is not 
noticeable, thus the excess number of monitor units and treatment time lead to the increasing in integral dose. In other 
hand, in both techniques the intersecting area between the bladder and PTV is the same. Therefore, the little differences 
in average dose of bladder in both techniques has not the radical role on increasing of integral dose in IMRT.  Contrary to 
bladder in rectum beside of the bigger intersecting volume between PTV and rectum for IMRT plans (10mm increasing of 
CTV towards rectum in IMRT against 8mm in 3DCRT), the reduction of average dose is noticeable in IMRT vs. 3DCRT. In 
rectum the discrepancy of average dose has bigger weight to increasing of integral dose in 3DCRT while the monitor unit 
and treatment time have been increasing in IMRT.  This means that in IMRT regarding to the dose of target volume and 
increased amount of prescribed dose (80Gy) vs. 3DCRT (70Gy), the healthy tissues received the same dose similar to 
3DCRT and it is the worthy benefit, while the target volumes in this method attained highest dose and the results of 
treatment became better, obviously.  
In addition, we infer from this study that IMRT proved better and precise conformation of dose distribution and concavity 
according to the target volume vs. 3DCRT (Figures 2a, 2b and 2c). 3DCRT also has the acceptable results according to 
H.I and C.I. Both treatments have good results in prostate cancer treatment but according to the results, the ability of 
escalation prescribed dose to PTV, IMRT has the better condition from the clinical view while preserved organs at risk in 
the better condition. 
The data provided evidence that it is necessary to consider the integral dose, conformity and homogeneity indexes as the 
important factors for choosing the optimal treatment plan, especially for the prostate cancer treatment. 
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